Zhejiang Huahai Pharmaceutical Subsidiaries Get Regulatory Nod for Tumor Clinical Trial; Shares Down 3%
Zhejiang Huahai Pharmaceutical Subsidiaries Get Regulatory Nod for Tumor Clinical Trial; Shares Down 3%
华海药业子公司获肿瘤临床试验监管批准;股价下跌3%。
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册